Releases
VBIV
--
0.00%
--
  • All
  • Financials
  • Insiders
More
Webull provides the latest VBI Vaccines (VBIV) stock and general news. This information may help you make smarter investment decisions.
About VBIV
VBI Vaccines Inc. is a development-stage biotechnology company. The Company's principal products include cytomegalovirus (CMV) Vaccine Candidate, enveloped Virus Like Particle (eVLP) Vaccine Platform and Lipid Particle Vaccine (LPV) Vaccine Platform. The Company is also engaged in the research and development (R and D) activity. The Company's subsidiaries includes Variation Biotechnologies (US), Inc. (VBI US) and Variation Biotechnologies Inc. (VBI Cda).